Publications by authors named "L A Kiseleva"

Objective: To justify the optimal method for determining indocyanine green plasma disappearance rate (PDR).

Material And Methods: We analyzed PDR in intensive care units. Indocyanine green was administered intravenously at a dose of 0.

View Article and Find Full Text PDF

This work is aimed at creating a modified invasive technique for assessing the liver's functional reserves. A study of the degree of hepatodepression is carried out by measuring the plasma elimination of indocyanine green using the method of optical densitometry. This paper presents test results for an aqueous solution and an albumin solution, as well as the results of measurements of plasma elimination of indocyanine green for patients with liver disease.

View Article and Find Full Text PDF

Bioelectrochemical systems such as microbial fuel cells (MFCs) are promising new technologies for efficient removal of organic compounds from industrial wastewaters, including that generated from swine farming. We inoculated two pairs of laboratory-scale MFCs with sludge granules from a beer wastewater-treating anaerobic digester (IGBS) or from sludge taken from the bottom of a tank receiving swine wastewater (SS). The SS-inoculated MFC outperformed the IGBS-inoculated MFC with regard to COD and VFA removal and electricity production.

View Article and Find Full Text PDF

Psoriasis is a common inflammatory skin disease with complex etiology and chronic progression. To provide novel insights into the regulatory molecular mechanisms of the disease, we performed RNA sequencing analysis of 14 pairs of skin samples collected from patients with psoriasis. Subsequent pathway analysis and extraction of the transcriptional regulators governing psoriasis-associated pathways was executed using a combination of the MetaCore Interactome enrichment tool and the cisExpress algorithm, followed by comparison to a set of previously described psoriasis response elements.

View Article and Find Full Text PDF
Article Synopsis
  • Malignant glioma is a common and aggressive brain tumor, with poor prognosis for high-grade cases.
  • Recent research explores the use of therapeutic viruses to treat these tumors, specifically a modified influenza A virus.
  • The study showed that this recombinant virus effectively targets and inhibits glioma cells in lab settings and in rat models, indicating a potential new treatment avenue for malignant gliomas.
View Article and Find Full Text PDF